Keyphrases
Adjuvant Therapy
100%
Melanoma
100%
Interferon Treatment
100%
Adjuvant Interferon
100%
Interferon-α (IFN-α)
75%
Tolerability
50%
Metastatic Melanoma
50%
Side Effect Profile
25%
Patient Benefit
25%
Poor Prognosis
25%
Patient Selection
25%
Effective Compounds
25%
Cost-benefit
25%
Treatment Decisions
25%
Median Survival
25%
Disease-free Survival
25%
Molecular Profile
25%
Cytokine Profile
25%
Interferon Therapy
25%
Biomarker Data
25%
Breslow Thickness
25%
Stage IV Melanoma
25%
Primary Lesion
25%
Positive Lymph Node Ratio
25%
Emerging Biomarkers
25%
Guide Selection
25%
American Joint Commission on Cancer
25%
Staging Criteria
25%
Immunologic Markers
25%
Medicine and Dentistry
Interferon
100%
Melanoma
100%
Adjuvant Therapy
80%
Malignant Neoplasm
20%
Biological Marker
20%
Lymph Node
20%
Cytokine
20%
Side Effect
20%
Cost Benefit Analysis
20%
Disease Free Survival
20%
Metastatic Melanoma
20%
Diseases
20%
Nursing and Health Professions
Interferon
100%
Melanoma
100%
Adjuvant Therapy
80%
Side Effect
20%
Malignant Neoplasm
20%
Biological Marker
20%
Cost Benefit Analysis
20%
Disease Free Survival
20%
Metastatic Melanoma
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Interferon
100%
Tolerability
40%
Biological Marker
20%
Malignant Neoplasm
20%
Side Effect
20%
Cytokine
20%
Disease Free Survival
20%
Metastatic Melanoma
20%
Diseases
20%